Gland Pharma Ltd.NSE: GLAND

Gland Pharma Ltd. Press Release Jul 29 2026

· Issued by Gland Pharma Ltd. via NSE India

Filed with NSE · · 2 pages · English

Release

Gland Pharma Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Gland Pharma receives approval for Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials".

Gland Pharma Ltd. on 6ix

Earlier from Gland Pharma

Later from Gland Pharma

All Gland Pharma news releases